30.04.2024 12:48:23
|
Eli Lilly And Co. Q1 Profit Increases, beats estimates
(RTTNews) - Eli Lilly And Co. (LLY) revealed earnings for its first quarter that increased from the same period last year and beat the Street estimates.
The company's earnings totaled $2.24 billion, or $2.48 per share. This compares with $1.34 billion, or $1.49 per share, in last year's first quarter.
Excluding items, Eli Lilly And Co. reported adjusted earnings of $2.34 billion or $2.58 per share for the period.
Analysts on average had expected the company to earn $2.46 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 26.0% to $8.77 billion from $6.96 billion last year.
Eli Lilly And Co. earnings at a glance (GAAP) :
-Earnings (Q1): $2.24 Bln. vs. $1.34 Bln. last year. -EPS (Q1): $2.48 vs. $1.49 last year. -Revenue (Q1): $8.77 Bln vs. $6.96 Bln last year.
-Guidance: Full year EPS guidance: $13.50 - $14.00 Full year revenue guidance: $42.4 - $43.6 Bln
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
17.01.25 |
Börse New York in Grün: S&P 500 nachmittags stärker (finanzen.at) | |
17.01.25 |
Starker Wochentag in New York: S&P 500 klettert mittags (finanzen.at) | |
14.01.25 |
NYSE-Handel: S&P 500 notiert zum Handelsende im Plus (finanzen.at) | |
14.01.25 |
Eli Lilly-Aktie sackt ab: Wachstum 2024 nicht so stark wie erhofft (dpa-AFX) | |
14.01.25 |
Dienstagshandel in New York: S&P 500 am Dienstagnachmittag in der Gewinnzone (finanzen.at) | |
14.01.25 |
S&P 500-Handel aktuell: S&P 500 im Minus (finanzen.at) | |
14.01.25 |
Eli Lilly shares fall after revenue miss for blockbuster weight-loss drugs (Financial Times) | |
14.01.25 |
S&P 500-Papier Eli Lilly-Aktie: So viel Gewinn hätte ein Eli Lilly-Investment von vor 3 Jahren eingefahren (finanzen.at) |
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 710,00 | -3,74% |